tiprankstipranks
Cocrystal Pharma advances CDI-988 into Phase 1 MAD cohorts
PremiumThe FlyCocrystal Pharma advances CDI-988 into Phase 1 MAD cohorts
2M ago
Cocrystal Pharma price target lowered to $7 from $10 at H.C. Wainwright
Premium
The Fly
Cocrystal Pharma price target lowered to $7 from $10 at H.C. Wainwright
3M ago
Cocrystal Pharma Engages Investors at Upcoming Conferences
Premium
Company Announcements
Cocrystal Pharma Engages Investors at Upcoming Conferences
3M ago
Cocrystal Pharma: CC-42344 inhibits activity in  ighly pathogenic avian flu
PremiumThe FlyCocrystal Pharma: CC-42344 inhibits activity in ighly pathogenic avian flu
5M ago
Cocrystal Pharma reports Q1 EPS (39c) vs (64c) last year
Premium
The Fly
Cocrystal Pharma reports Q1 EPS (39c) vs (64c) last year
7M ago
Cocrystal Pharma reports Q1 EPS (39c) vs (64c) last year
Premium
The Fly
Cocrystal Pharma reports Q1 EPS (39c) vs (64c) last year
7M ago
Cocrystal Pharma reports 2023 EPS ($1.87), consensus ($2.09)
PremiumThe FlyCocrystal Pharma reports 2023 EPS ($1.87), consensus ($2.09)
8M ago
Cocrystal Pharma Advances Influenza A Treatment Development
Premium
Company Announcements
Cocrystal Pharma Advances Influenza A Treatment Development
8M ago
Cocrystal Pharma receives pre-IND responses from FDA on oral CC-42344
Premium
The Fly
Cocrystal Pharma receives pre-IND responses from FDA on oral CC-42344
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100